Martin Patrick Murphy - 11 Jun 2026 Form 4 Insider Report for Century Therapeutics, Inc. (IPSC)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
12 Jun 2026, 17:06:49 UTC
Prior SEC filing
10 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Douglas Carr, Attorney-in-Fact

Key filing fact

Martin Patrick Murphy filed Form 4 for Century Therapeutics, Inc. (IPSC) on 12 Jun 2026.

Key facts

  • This page summarizes Martin Patrick Murphy's Form 4 filing for Century Therapeutics, Inc. (IPSC).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 12 Jun 2026, 17:06.

Change

  • Previous filing in this sequence was filed on 10 Apr 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002127581 Primary reporting owner

Murphy Martin Patrick

Relationship
Director
Address
C/O CENTURY THERAPEUTICS, INC., 25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA
Signature
/s/ Douglas Carr, Attorney-in-Fact
Signature date
12 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IPSC transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares
+74,000
Change %
Price
$0.000000*
Shares after
74,000
Date
11 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
74,000
Exercise price
$2.24
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option vests on the earlier of (a) June 11, 2027, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .